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● We decided to use 4 outcome measures that would be measured twice in patients; once at the 
beginning of the experiment and once at the conclusion of the 4 week testing period.
○ Numeric Pain Rating Scale (NPRS)6.
○ Patients will rate their pain from 1 (little to no pain) to 10 (pain requiring hospitalization). 
○ Life Satisfaction Questionnaire-117.
○ This questionnaire targets 11 life domains that may impact a subject, including: vocation, finances, 
leisure, general life satisfaction, contact with others, sexual life, self care, family life, partner 
relationship, physical health, and psychological health. 
○ Posture Analysis8.
○ Posture analysis will be completed using the Posture Screen Mobile application and will be used to 
determine any variations in the participant’s posture that may be related to discomfort or physical 
symptoms that they are experiencing. 
○ Gait Analysis9.
○ This analysis will use the Zeno Walkway and the Prokinetics Movement Analysis System to assess 
gait speed, step length, and step symmetry. 
● Protocol for randomized experimental study involving individuals 21 years or older who have been diagnosed with 
chronic pain and/or Parkinson’s Disease:
○ Inclusion criteria: diagnosis of chronic pain, Parkinson’s disease, or both; legally certified to use medical cannabis; 
English speaking; clearance from physician to participate; administration of medical cannabis using a legal form.
○ Exclusion criteria: diagnosed with another neurological disease; acute musculoskeletal injury in the past 2 weeks; 
acute systemic illness; uncontrolled hypertension (resting BP > 149/90); disoriented to person, place or time; 
resting HR greater than 100 bpm.
● Participants would be screened by a physical therapist in order to participate. Following screening, participants will 
provide informed consent and photo release, and be assigned a random ID number to maintain confidentiality. 
● Researchers would like a total of 80 participants, recruited from the Justice Grown Dispensary in Edwardsville PA. 
○ Subjects will be placed in 4 groups (see Figure):  1) chronic pain,  8 sessions of physical therapy (PT);  2 ) chronic 
pain, no PT ; 3) Parkinson’s disease , 8 session of PT, 4) Parkinson’s Disease, no PT.  All subjects will use medical 
cannabis.
● It is estimated that more than 20% of Americans 
experience chronic pain1.
● There is a strong correlation between chronic pain 
and diminished performance of daily activities2.
● In 2016, opioid medications recorded 
approximately 38,000 deaths due to overdose3.
● Parkinson’s Disease currently affects approximately 
60,000 Americans per year and an estimated 10 
million people worldwide4.
● Common symptoms in patients with Parkinson’s 
Disease  include pain, resting tremor, fatigue, 
decreased movement, muscle rigidity, impaired 
postural control and balance, difficulty with gait 
(freezing gait), and sleep disturbances.
● Results of self-reported assessments of neurological 
disability between current cannabis users and non-
users and found that the level of disability was 44% 
less with the users compared to non-users5.
● There is currently limited research exploring how 
physical therapy coupled with medical cannabis use 
in patients with chronic pain and/or Parkinson's 
Disease.
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PHYSICAL THERAPY IMPLICATIONS 
The purpose of this study is to determine the effects of 
medical cannabis coupled with skilled physical therapy 
in patients with chronic pain and/or Parkinson’s 
Disease.
● We believe that the interaction between medical 
cannabis coupled and  PT in patients with chronic pain 
and/or Parkinson’s Disease will lead to better overall 
patient outcomes and is a need for future research.
● There is currently no literature exploring how  PT 
coupled with medical cannabis in patients with chronic 
pain and/or Parkinson’s Disease affects life satisfaction. 
Therefore, we believe this research to be appropriate 
and necessary.
● In future research, inclusion and exclusion criteria can 
be adjusted based on the preferences of future 
researchers as well as current state legislation.
● Both PT and medical cannabis have been shown to 
be effective in patients with Parkinson’s Disease and  
chronic pain. 
● We hypothesize that the combination of skilled PT 
coupled with medical cannabis will increase positive 
results in patients.
● This research will allow physical therapists to learn 
about the potential benefits of medical cannabis and 
how it can aid their patients, and pass that 
information on the colleagues, other medical 
professionals, patients and families.
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● PT interventions would be customized to 
participants, including, but not limited to:
Balance, strength, or flexibility training; 
walking, functional mobility, manual therapy.
● Following the study, 8 session of Physical 
therapy will. be offered to participants who 
were not placed in the PT group.
Figure:  Experimental Groups
